| Execution period | Vesting schedule of 24 months; exercise period up to 36 months from vesting |
|---|
NSE filing, NSE: 360ONE. Summary written from the filing by ALFA Finder's alert engine.
360 One Wam Ltd: key numbers
- Share price
- ₹991.00
- Market cap
- ₹42,502 Cr
- Revenue (annual)
- ₹4,362 Cr
- Net profit (annual)
- ₹1,216 Cr
- P/E (TTM)
- 34.1×Sector 19.7×
- Promoter holding
- 5.88%-0.32% QoQ
- FII holding
- 56.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from 360 One Wam Ltd
All →360 One Wam Other Announcement
360 ONE WAM sold 1,200 equity shares worth Rs.12,26,292 on NSE on 23 October 2026 under a PIT disclosure. The seller is a Designated Person, and the holding fell to zero.
- Value
- ₹0.12 Cr
360 One Wam Employee Stock Options
360 ONE WAM LIMITED allotted 4,61,384 equity shares to employees following the exercise of stock options under its ESOP scheme.
360 One Wam Debt & Borrowing: ₹200 Cr
360 ONE WAM redeemed its ₹200 Crore Commercial Paper in full at maturity on 22 October 2026. The entire principal was repaid to investors.
- Value
- ₹200.0 Cr
360 One Wam Convertible Warrants
UBS AG warrants converted into 2.05 crore equity shares at Rs.1,030 each. Balance 75% exercise price of Rs.1,583.85 Crore received by 360 ONE WAM.
- Value
- ₹1,584 Cr
360 One Wam Convertible Warrants
360 ONE WAM allotted 2,05,02,939 shares to UBS AG on warrant conversion at Rs.1,030 each. Consideration: Rs.2,111.80 Crore, giving UBS ~4.8%.
- Value
- ₹2,112 Cr
360 One Wam Earnings Call Transcript: Key Takeaways
Q2 FY27 earnings call highlights solid AUM growth to ₹9 lakh Cr (up 31% YoY). PAT stood at ₹302 Cr.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.